357 related articles for article (PubMed ID: 35455977)
1. Systematic Review of the Common Pathophysiological Mechanisms in COVID-19 and Neurodegeneration: The Role of Bioactive Compounds and Natural Antioxidants.
Choe K; Park HY; Ikram M; Lee HJ; Park TJ; Ullah R; Kim MO
Cells; 2022 Apr; 11(8):. PubMed ID: 35455977
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer's Disease Patients.
Chiricosta L; Gugliandolo A; Mazzon E
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948400
[TBL] [Abstract][Full Text] [Related]
3. [SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies].
Putilina MV; Grishin DV
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(8. Vyp. 2):58-64. PubMed ID: 33016678
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 as a Risk Factor for Alzheimer's Disease.
Golzari-Sorkheh M; Weaver DF; Reed MA
J Alzheimers Dis; 2023; 91(1):1-23. PubMed ID: 36314211
[TBL] [Abstract][Full Text] [Related]
5. Pathological Features and Neuroinflammatory Mechanisms of SARS-CoV-2 in the Brain and Potential Therapeutic Approaches.
Sodagar A; Javed R; Tahir H; Razak SIA; Shakir M; Naeem M; Yusof AHA; Sagadevan S; Hazafa A; Uddin J; Khan A; Al-Harrasi A
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883527
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms highlighting the potential role of COVID-19 in the development of neurodegenerative diseases.
Rahmani B; Ghashghayi E; Zendehdel M; Baghbanzadeh A; Khodadadi M
Physiol Int; 2022 Jun; 109(2):135-162. PubMed ID: 35895572
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 and Alzheimer's Disease: Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved.
Pomilio AB; Vitale AA; Lazarowski AJ
Curr Med Chem; 2023; 30(35):3993-4031. PubMed ID: 36200215
[TBL] [Abstract][Full Text] [Related]
8. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
9. The impact of COVID-19 on diagnostic biomarkers in neuropsychiatric and neuroimmunological diseases: a review.
Dadkhah M; Talei S; Doostkamel D; Molaei S; Rezaei N
Rev Neurosci; 2022 Jan; 33(1):79-92. PubMed ID: 34087964
[TBL] [Abstract][Full Text] [Related]
10. Neuropathies and neurological dysfunction induced by coronaviruses.
Gholami M; Safari S; Ulloa L; Motaghinejad M
J Neurovirol; 2021 Jun; 27(3):380-396. PubMed ID: 33983506
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease in elderly COVID-19 patients: potential mechanisms and preventive measures.
Wang H; Lu J; Zhao X; Qin R; Song K; Xu Y; Zhang J; Chen Y
Neurol Sci; 2021 Dec; 42(12):4913-4920. PubMed ID: 34550494
[TBL] [Abstract][Full Text] [Related]
12. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
13. Headache in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Narrative Review.
Tolebeyan AS; Zhang N; Cooper V; Kuruvilla DE
Headache; 2020 Nov; 60(10):2131-2138. PubMed ID: 33017479
[TBL] [Abstract][Full Text] [Related]
14. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
15. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms of SARS-CoV-2/COVID-19 Pathogenicity on the Central Nervous System: Bridging Experimental Probes to Clinical Evidence and Therapeutic Interventions.
Groppa SA; Ciolac D; Duarte C; Garcia C; Gasnaș D; Leahu P; Efremova D; Gasnaș A; Bălănuță T; Mîrzac D; Movila A
Adv Exp Med Biol; 2022; 1376():1-27. PubMed ID: 34735712
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress and COVID-19-associated neuronal dysfunction: mechanisms and therapeutic implications.
Bowen DR; Pathak S; Nadar RM; Parise RD; Ramesh S; Govindarajulu M; Moore A; Ren J; Moore T; Dhanasekaran M
Acta Biochim Biophys Sin (Shanghai); 2023 Jun; 55(8):1153-1167. PubMed ID: 37357527
[TBL] [Abstract][Full Text] [Related]
18. Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.
Naughton SX; Raval U; Pasinetti GM
J Alzheimers Dis; 2020; 76(1):21-25. PubMed ID: 32538855
[TBL] [Abstract][Full Text] [Related]
19. Coronaviruses: Innate Immunity, Inflammasome Activation, Inflammatory Cell Death, and Cytokines.
Lee S; Channappanavar R; Kanneganti TD
Trends Immunol; 2020 Dec; 41(12):1083-1099. PubMed ID: 33153908
[TBL] [Abstract][Full Text] [Related]
20. Human and novel coronavirus infections in children: a review.
Rajapakse N; Dixit D
Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
